175 related articles for article (PubMed ID: 21922144)
1. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
2. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages.
Fujiwara Y; Komohara Y; Ikeda T; Takeya M
Cancer Sci; 2011 Jan; 102(1):206-11. PubMed ID: 21073634
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.
Shiraishi D; Fujiwara Y; Komohara Y; Mizuta H; Takeya M
Biochem Biophys Res Commun; 2012 Aug; 425(2):304-8. PubMed ID: 22842565
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition.
Fujiwara Y; Takeya M; Komohara Y
Biomed Res Int; 2014; 2014():348539. PubMed ID: 24738052
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and Antimetastatic Activity of Synthetic Hydroxystilbenes Through Inhibition of Lymphangiogenesis and M2 Macrophage Differentiation of Tumor-associated Macrophages.
Kimura Y; Sumiyoshi M; Baba K
Anticancer Res; 2016 Jan; 36(1):137-48. PubMed ID: 26722037
[TBL] [Abstract][Full Text] [Related]
6. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation.
Takaishi K; Komohara Y; Tashiro H; Ohtake H; Nakagawa T; Katabuchi H; Takeya M
Cancer Sci; 2010 Oct; 101(10):2128-36. PubMed ID: 20860602
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells.
Kimura Y; Sumiyoshi M
Eur J Pharmacol; 2015 Jan; 746():115-25. PubMed ID: 25445053
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages.
Sumiyoshi M; Taniguchi M; Baba K; Kimura Y
Phytomedicine; 2015 Jul; 22(7-8):759-67. PubMed ID: 26141763
[TBL] [Abstract][Full Text] [Related]
10. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
11. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
12. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
13. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes.
Ohnishi K; Komohara Y; Sakashita N; Iyama K; Murayama T; Takeya M
Pathol Int; 2010 Jan; 60(1):27-34. PubMed ID: 20055949
[TBL] [Abstract][Full Text] [Related]
14. STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
Andersen MN; Etzerodt A; Graversen JH; Holthof LC; Moestrup SK; Hokland M; Møller HJ
Cancer Immunol Immunother; 2019 Mar; 68(3):489-502. PubMed ID: 30637473
[TBL] [Abstract][Full Text] [Related]
15. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages.
Sun L; Chen B; Jiang R; Li J; Wang B
Cell Immunol; 2017 Jan; 311():86-93. PubMed ID: 27825563
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
Chen W; Ma T; Shen XN; Xia XF; Xu GD; Bai XL; Liang TB
Cancer Res; 2012 Mar; 72(6):1363-72. PubMed ID: 22287548
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
Domínguez-Soto A; Sierra-Filardi E; Puig-Kröger A; Pérez-Maceda B; Gómez-Aguado F; Corcuera MT; Sánchez-Mateos P; Corbí AL
J Immunol; 2011 Feb; 186(4):2192-200. PubMed ID: 21239715
[TBL] [Abstract][Full Text] [Related]
19. Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.
Xue N; Zhou Q; Ji M; Jin J; Lai F; Chen J; Zhang M; Jia J; Yang H; Zhang J; Li W; Jiang J; Chen X
Sci Rep; 2017 Jan; 7():39011. PubMed ID: 28045028
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
